These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18955501)

  • 1. Protein kinase Czeta represses the interleukin-6 promoter and impairs tumorigenesis in vivo.
    Galvez AS; Duran A; Linares JF; Pathrose P; Castilla EA; Abu-Baker S; Leitges M; Diaz-Meco MT; Moscat J
    Mol Cell Biol; 2009 Jan; 29(1):104-15. PubMed ID: 18955501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of RANTES and IL-8 expression in lung adenocarcinoma cells.
    Henriquet C; Gougat C; Combes A; Lazennec G; Mathieu M
    Lung Cancer; 2007 May; 56(2):167-74. PubMed ID: 17207890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene.
    Zhang Y; Liao M; Dufau ML
    Mol Cell Biol; 2006 Sep; 26(18):6748-61. PubMed ID: 16943418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis.
    Duran A; Linares JF; Galvez AS; Wikenheiser K; Flores JM; Diaz-Meco MT; Moscat J
    Cancer Cell; 2008 Apr; 13(4):343-54. PubMed ID: 18394557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis.
    Joshi J; Fernandez-Marcos PJ; Galvez A; Amanchy R; Linares JF; Duran A; Pathrose P; Leitges M; Cañamero M; Collado M; Salas C; Serrano M; Moscat J; Diaz-Meco MT
    EMBO J; 2008 Aug; 27(16):2181-93. PubMed ID: 18650932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
    Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
    Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCH 51344 inhibits ras transformation by a novel mechanism.
    Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
    Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
    Butler AM; Scotti Buzhardt ML; Erdogan E; Li S; Inman KS; Fields AP; Murray NR
    Oncotarget; 2015 Jun; 6(17):15297-310. PubMed ID: 25915428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical protein kinase C{iota} is required for bronchioalveolar stem cell expansion and lung tumorigenesis.
    Regala RP; Davis RK; Kunz A; Khoor A; Leitges M; Fields AP
    Cancer Res; 2009 Oct; 69(19):7603-11. PubMed ID: 19738040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation.
    García-Silva S; Aranda A
    Mol Cell Biol; 2004 Sep; 24(17):7514-23. PubMed ID: 15314161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activation mechanisms of protein kinase Czeta and its cellular function].
    Xu SJ; Cong B
    Sheng Li Ke Xue Jin Zhan; 2005 Oct; 36(4):309-13. PubMed ID: 16408768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation by tyrosine phosphorylation as a prerequisite for protein kinase Cζ to mediate epidermal growth factor receptor signaling to ERK.
    Valkova C; Mertens C; Weisheit S; Imhof D; Liebmann C
    Mol Cancer Res; 2010 May; 8(5):783-97. PubMed ID: 20407013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms regulating protein kinase Czeta turnover and cellular transformation.
    Le Good JA; Brindley DN
    Biochem J; 2004 Feb; 378(Pt 1):83-92. PubMed ID: 14580237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis.
    Jo H; Zhang R; Zhang H; McKinsey TA; Shao J; Beauchamp RD; Ballard DW; Liang P
    Oncogene; 2000 Feb; 19(7):841-9. PubMed ID: 10702792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.
    Wang S; Raven JF; Koromilas AE
    Mol Cancer Res; 2010 May; 8(5):798-805. PubMed ID: 20407011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
    Lin X; Gelman IH
    Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis.
    Shaw AT; Meissner A; Dowdle JA; Crowley D; Magendantz M; Ouyang C; Parisi T; Rajagopal J; Blank LJ; Bronson RT; Stone JR; Tuveson DA; Jaenisch R; Jacks T
    Genes Dev; 2007 Mar; 21(6):694-707. PubMed ID: 17369402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo.
    Steven A; Heiduk M; Recktenwald CV; Hiebl B; Wickenhauser C; Massa C; Seliger B
    Mol Cancer Res; 2015 Aug; 13(8):1248-62. PubMed ID: 25934695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.